Rare Cancers
Commons · Question 2281 · Tabled 18 May 2026 · Department of Health and Social Care · Official record
Answered 28 May 2026
Question
Asked by Matt Vickers
To ask the Secretary of State for Health and Social Care, what progress his Department has made on reviewing regulations of treatments for rare diseases and orphan drugs as required by the Rare Cancers Act 2026.
Answer
Answered by Preet Kaur Gill, 28 May 2026
Following the launch of the new rare disease therapy framework, the Department has made significant progress in reviewing and proposing updates to the regulation of treatments for rare diseases and orphan drugs. Building on earlier policy commitments, the...